Activating Compound | Comment | Organism | Structure |
---|---|---|---|
apolipoprotein C-II | required | Rattus norvegicus | |
heparin | increases hydrolytic activity | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
apolipoprotein C I | - |
Rattus norvegicus | |
apolipoprotein C III | - |
Rattus norvegicus | |
diisopropyl fluorophosphate | - |
Rattus norvegicus | |
NaCl | 0.5 M, 80% inhibition, 1 M, 90% inhibition | Rattus norvegicus | |
phenylmethylsulfonyl fluoride | - |
Rattus norvegicus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
34000 | - |
x * 34000, SDS-PAGE, equilibrium sedimentation in presence of 6 M guanidine HCl and 0.1% mercaptoethanol | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
side-chain modification | glycoprotein | Rattus norvegicus |
Purification (Comment) | Organism |
---|---|
- |
Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
10.77 | - |
- |
Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | no absolute specificity for monolayers of triglycerides, hydrolysis of diglyceride monolayers at comparable rates | Rattus norvegicus | ? | - |
? | |
trioctanoin + H2O | - |
Rattus norvegicus | ? | - |
? | |
triolein + H2O | - |
Rattus norvegicus | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 34000, SDS-PAGE, equilibrium sedimentation in presence of 6 M guanidine HCl and 0.1% mercaptoethanol | Rattus norvegicus |